CONTOLI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 18.123
AS - Asia 8.458
EU - Europa 5.296
SA - Sud America 1.358
Continente sconosciuto - Info sul continente non disponibili 452
AF - Africa 189
OC - Oceania 34
AN - Antartide 1
Totale 33.911
Nazione #
US - Stati Uniti d'America 17.520
SG - Singapore 3.286
CN - Cina 1.832
IT - Italia 1.730
BR - Brasile 1.041
VN - Vietnam 915
DE - Germania 797
HK - Hong Kong 691
UA - Ucraina 505
BD - Bangladesh 472
FI - Finlandia 470
GB - Regno Unito 449
TR - Turchia 344
FR - Francia 307
CA - Canada 265
SE - Svezia 241
JP - Giappone 219
PL - Polonia 205
RU - Federazione Russa 196
ID - Indonesia 182
IN - India 164
MX - Messico 152
AR - Argentina 122
NL - Olanda 108
ZA - Sudafrica 67
IQ - Iraq 55
PK - Pakistan 53
ES - Italia 50
CO - Colombia 48
EC - Ecuador 40
LT - Lituania 39
UZ - Uzbekistan 36
AT - Austria 32
BE - Belgio 32
PY - Paraguay 29
MY - Malesia 28
AU - Australia 27
JM - Giamaica 27
PH - Filippine 27
VE - Venezuela 26
MA - Marocco 24
NI - Nicaragua 23
CZ - Repubblica Ceca 22
HN - Honduras 21
KR - Corea 21
CR - Costa Rica 19
TT - Trinidad e Tobago 19
KE - Kenya 18
SA - Arabia Saudita 18
TN - Tunisia 17
CL - Cile 16
GT - Guatemala 16
IE - Irlanda 16
PE - Perù 16
SV - El Salvador 16
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
EE - Estonia 13
EG - Egitto 13
JO - Giordania 13
UY - Uruguay 13
PR - Porto Rico 11
TW - Taiwan 10
AZ - Azerbaigian 9
BB - Barbados 9
CH - Svizzera 9
AL - Albania 8
NP - Nepal 8
CW - ???statistics.table.value.countryCode.CW??? 7
HR - Croazia 7
HU - Ungheria 7
IL - Israele 7
ET - Etiopia 6
GE - Georgia 6
GP - Guadalupe 6
KH - Cambogia 6
NZ - Nuova Zelanda 6
PA - Panama 6
PT - Portogallo 6
RO - Romania 6
DK - Danimarca 5
IR - Iran 5
KZ - Kazakistan 5
LB - Libano 5
LK - Sri Lanka 5
MK - Macedonia 5
OM - Oman 5
RS - Serbia 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
EU - Europa 4
GY - Guiana 4
MD - Moldavia 4
NG - Nigeria 4
CY - Cipro 3
GR - Grecia 3
KG - Kirghizistan 3
MU - Mauritius 3
SC - Seychelles 3
SI - Slovenia 3
Totale 33.411
Città #
Ashburn 2.202
Singapore 2.013
San Jose 1.249
Fairfield 1.233
Woodbridge 1.028
Houston 979
Council Bluffs 771
Santa Clara 751
Hong Kong 679
Beijing 568
Jacksonville 558
Chandler 536
Seattle 510
Ann Arbor 505
Wilmington 486
Cambridge 426
Munich 378
Los Angeles 362
New York 360
Ho Chi Minh City 310
Helsinki 280
Dallas 279
Milan 241
Hanoi 210
Tokyo 206
Warsaw 190
Ferrara 189
Izmir 186
Nanjing 178
Princeton 169
Lauterbourg 163
Jakarta 134
Chicago 120
Rome 112
São Paulo 110
San Diego 108
Toronto 94
Boardman 93
Shanghai 89
Mexico City 88
Atlanta 86
London 79
Orem 78
Buffalo 74
Phoenix 72
Addison 65
San Francisco 60
Brooklyn 57
Turku 57
Dearborn 55
Frankfurt am Main 55
Montreal 52
Bologna 50
Nanchang 50
Washington 50
Da Nang 49
Shenyang 49
Tianjin 47
Denver 46
Hefei 44
North Bergen 44
The Dalles 41
Chennai 40
Mountain View 36
Naples 36
Boston 35
Changsha 32
Salt Lake City 32
Tashkent 32
Moscow 31
Nuremberg 31
Rio de Janeiro 31
Turin 31
Hebei 30
Brussels 29
Haiphong 29
Jiaxing 29
Amsterdam 28
Columbus 28
Redwood City 28
Johannesburg 27
Falls Church 26
Florence 26
Guangzhou 26
Brasília 25
Dhaka 24
Manchester 24
Stockholm 24
Jinan 22
Lappeenranta 22
Norwalk 22
Palermo 22
Tampa 22
Baghdad 21
Managua 21
Philadelphia 21
Miami 20
Newark 20
Ankara 19
Bremen 19
Totale 21.424
Nome #
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 669
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 569
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 468
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 395
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 360
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 350
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 338
Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study 327
Targeting Th2 cells in asthmatic airways 317
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 312
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 308
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 292
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 286
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 278
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 277
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 274
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 272
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 268
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 262
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 258
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 255
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 253
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 248
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 244
A serum proteome signature to predict mortality in severe COVID-19 patients 241
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 240
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 238
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 234
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 234
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 232
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 230
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 229
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 229
Cellule staminali e patologia polmonare dell’adulto 228
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 228
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 227
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 227
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 224
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 219
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 216
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 211
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 211
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 209
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 208
Rhinovirus vaccination: the case against 206
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study 205
Models of infection and exacerbations in COPD. 204
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 203
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 202
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 201
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 200
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 199
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 199
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 199
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 199
From intensive care to rehabilitation: survey on the satisfaction with care received during prolonged hospitalization for COVID-19 at a northern Italian university hospital 198
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 196
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 193
Asthma: A Chronic Infectious Disease? 193
A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD: A proposal for COPD management 192
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 190
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 190
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients 189
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 189
Left atrial pressure in patients with respiratory failure due to SARS-CoV-2 infection and supraventricular arrythmias 186
Disease awareness in patients with COPD: measurement and extent 185
Air Pollution Exposure Impairs Airway Epithelium IFN-β Expression in Pre-School Children 185
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 184
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations 184
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 184
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 182
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 181
Interactions of airway pathogens and inflammatory processes 181
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 180
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 179
Pathophysiology of viral-induced exacerbations of COPD 176
The Additional Value of Lower Respiratory Tract Sampling in the Diagnosis of COVID-19: A Real-Life Observational Study 175
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 175
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 174
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 174
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 174
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 174
Interactions of airway pathogens and inflammatory processes 172
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 171
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 171
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 170
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 169
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 164
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 164
Deficient immune response to viral infections in children predicts later Asthma persistence 164
Small airway disease in asthma: pathophysiological and diagnostic considerations 163
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 163
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations 163
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 162
Increased sHLA-G is associated with improved COVID-19 outcome and reduced neutrophil adhesion 162
Effects of aclidinium on determinants of COPD severity: Symptoms and quality of life 161
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease 160
Humoral and adaptive immune responses to SARS-CoV-2 vaccine 160
Rhinovirus-induced bronchial mucosal inflammatory response in asthma 158
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 158
Totale 22.530
Categoria #
all - tutte 158.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.055
Totale 163.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.215 0 0 0 140 56 79 84 98 65 115 158 420
2022/20231.435 184 62 69 144 205 191 107 117 174 26 104 52
2023/2024976 73 105 48 29 59 170 37 68 34 34 49 270
2024/20254.677 99 107 362 166 528 445 208 289 832 520 593 528
2025/202612.876 1.081 491 1.028 1.448 1.906 788 1.541 746 1.209 1.259 874 505
2026/20274.031 425 988 1.147 1.471 0 0 0 0 0 0 0 0
Totale 33.911